Company News
LTS congratulates its business partner Dr. Reddy’s Laboratories Ltd. for the US launch of its Buprenorphine and Naloxone Sublingual Film.
The new LTS webinar “Oral Thin Films – Tailoring Therapy Need” presented by Dr. Marco Emgenbroich will be held on Nov. 29, 3pm CET/ 9am EST. Join our free webinar.
At the meeting of the LTS Supervisory Board on April 23rd 2018, Prof. Dr. Norbert Loos resigned as Chairman of the Supervisory Board of the LTS AG. Subsequently, the LTS AG Supervisory Board elected Prof. Dr. Christof Hettich as its new Chairman.
Initial results of the market analysis indicate there is a substantial market for AP-CD/LD to potentially serve hundreds of thousands of patients suffering with Parkinson's Disease.
Smart Patch Offers a Simpler Way for Patients to Administer and Monitor Medicine Intake
